BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26092177)

  • 1. Diffuse systemic large B-cell lymphoma with secondary skin involvement.
    Lloret-Ruiz C; Molés-Poveda P; Barrado-Solís N; Gimeno-Carpio E
    Actas Dermosifiliogr; 2015 Oct; 106(8):685-7. PubMed ID: 26092177
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary bone marrow lymphoma is a rare neoplasm with poor outcome: case series from single tertiary care centre and review of literature.
    Bhagat P; Sachdeva MU; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Law A; Malhotra P
    Hematol Oncol; 2016 Mar; 34(1):42-8. PubMed ID: 25407700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma--De Novo Occurrence or Transformation.
    Gajendra S; Jha B; Goel S; Sahni T; Dorwal P; Sachdev R
    Turk J Haematol; 2015 Dec; 32(4):371-2. PubMed ID: 26376833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ictus cerebellopontine as first manifestation of an intravascular diffuse large B cell lymphoma involving at the kidney].
    Sagüés M; Paredes V; Altés J; Fernández de Sevilla A
    Med Clin (Barc); 2015 Jan; 144(1):48-9. PubMed ID: 24698716
    [No Abstract]   [Full Text] [Related]  

  • 5. De novo CD5-positive diffuse large B cell lymphoma solely presenting as multiple subcutaneous nodules.
    Takahashi T; Kazama Y; Shimizu H; Yoshimoto M; Tsujisaki M; Imai K
    Acta Haematol; 2002; 107(4):230-3. PubMed ID: 12053152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
    Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
    Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
    Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
    [No Abstract]   [Full Text] [Related]  

  • 9. Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy.
    Yokoo M; Kojima K; Sano H; Kai K; Arakawa F; Ohshima K; Matsunaga T; Kimura S
    Ann Hematol; 2019 Jun; 98(6):1501-1503. PubMed ID: 30406822
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of a primary cardiac B-cell lymphoma.
    Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A
    Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic impact of bone marrow involvement (BMI) and therapies in diffuse large B cell lymphoma].
    Yi SH; Xu Y; Zou DH; An G; Zhao YZ; Qi JY; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):307-12. PubMed ID: 19799125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous B-cell lymphoma, leg type, with age-adapted combinations of chemotherapies and rituximab.
    Grange F; Maubec E; Bagot M; Beylot-Barry M; Joly P; Dalle S; Delaporte E; Dereure O; Bachelez H; Vergier B; Petrella T; D'Incan M
    Arch Dermatol; 2009 Mar; 145(3):329-30. PubMed ID: 19289772
    [No Abstract]   [Full Text] [Related]  

  • 13. A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
    Advani P; Paulus A; Murray P; Jiang L; Goff R; Pooley R; Jain M; Garner H; Foran J
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e117-20. PubMed ID: 25617034
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid bone marrow dissemination after surgery in localized gastric diffuse large B-cell lymphoma: a case report.
    Isoda A; Hatsumi N; Ogawa Y; Matsumoto M; Sawamura M
    Int J Hematol; 2006 Dec; 84(5):471-2. PubMed ID: 17189234
    [No Abstract]   [Full Text] [Related]  

  • 15. Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review.
    Cao C; Liu T; Zhu H; Wang L; Kai S; Xiang B
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e145-50. PubMed ID: 25225082
    [No Abstract]   [Full Text] [Related]  

  • 16. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
    Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
    Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
    Ferrari A; Luppi M; Lazzerini A; Potenza L; Cavallini GM; Torelli G
    Lancet Oncol; 2006 Mar; 7(3):274. PubMed ID: 16510339
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.